Two Decades of Commercializing Nanotechnology for Medical Devices: Real Products Helping Real Humans

T.J. Webster
Northeastern University,
United States

Keywords: medical device, nanotechnology, tissue


There is an acute shortage of organs due to disease, trauma, congenital defect, and most importantly, age related maladies. While tissue engineering (and nanotechnology) has made great strides towards improving tissue growth, infection control has been largely forgotten. Critically, as a consequence, the Centers for Disease Control have predicted more deaths from antibiotic-resistant bacteria than all cancers combined by 2050. Moreover there has been a lack of translation to real commercial products. This talk will summarize how nanotechnology can be used to increase tissue growth and decrease implant infection without using antibiotics (while getting regulatory approval). Our group has shown that same nanofeatures, nano-modifications, and nanoparticles can reduce bacterial growth without using antibiotics. This talk will summarize techniques and efforts to create nanofeatures for a wide range of medical devices and tissue engineering applications, particularly those that have received FDA approval and are currently being implanted in humans.